UDP-GlcNAc Disodium Salt |
| カタログ番号GC33787 |
UDP-GlcNAc 二ナトリウム塩 (UDP-α-D-N-Acetylglucosamine 二ナトリウム塩) は、O-GlcNAc トランスフェラーゼ (OGT) のドナー基質です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 91183-98-1
Sample solution is provided at 25 µL, 10mM.
;)
_1-7.$$$37316672@70.jpg');)
;)
;)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
;)
;)
;)
_1124-1138.$$$35908550@30.jpg');)
_766-780.$$$37100057@30.jpg');)
_418-432.$$$36893736@30.jpg');)
_240-255.$$$35108512@29.jpg');)
_533-545.$$$36543525@28.jpg');)
_264-276.$$$36600053@22.jpg');)
_2214998.$$$@0.jpg');)
UDP-GlcNAc Disodium Salt is produced by the hexosamine biosynthesis pathway (HBP)[1]and acts as a precursor for several important biomolecules like glycosaminoglycans, which is an essential substrate for protein glycosylation reactions in mammals[2]. UDP-GlcNAc Disodium Salt is a donor substrate for glycosyltransferases, enzymes that attach sugar moieties to proteins, lipids, and nucleic acids, which is important in cellular signaling, adhesion, and immune responses[3]. UDP-GlcNAc Disodium Salt is primarily used in research on glycobiology[4] and the study of metabolic diseases, including diabetes[5] and cancer[6].
References:
[1]. Paneque A, Fortus H, Zheng J, et al. The Hexosamine Biosynthesis Pathway: Regulation and Function. Genes (Basel). 2023 Apr 18;14(4):933. doi: 10.3390/genes14040933. PMID: 37107691; PMCID: PMC10138107.
[2]. Ruegenberg S, Horn M, Pichlo C, et al. Loss of GFAT-1 feedback regulation activates the hexosamine pathway that modulates protein homeostasis. Nat Commun. 2020 Feb 4;11(1):687. doi: 10.1038/s41467-020-14524-5. PMID: 32019926; PMCID: PMC7000685.
[3]. Yang X, Qian K. Protein O-GlcNAcylation: emerging mechanisms and functions. Nat Rev Mol Cell Biol. 2017 Jul;18(7):452-465. doi: 10.1038/nrm.2017.22. Epub 2017 May 10. PMID: 28488703; PMCID: PMC5667541.
[4]. van Wijk XM, Thijssen VL, Lawrence R, et al. Interfering with UDP-GlcNAc metabolism and heparan sulfate expression using a sugar analogue reduces angiogenesis. ACS Chem Biol. 2013 Oct 18;8(10):2331-8. doi: 10.1021/cb4004332. Epub 2013 Sep 3. PMID: 23972127; PMCID: PMC3821560.
[5]. Slawson C, Copeland RJ, Hart GW. O-GlcNAc signaling: a metabolic link between diabetes and cancer? Trends Biochem Sci. 2010 Oct;35(10):547-55. doi: 10.1016/j.tibs.2010.04.005. Epub 2010 May 11. PMID: 20466550; PMCID: PMC2949529.
[6]. Pan X, Wilson M, Mirbahai L, McConville C, Arvanitis TN, Griffin JL, Kauppinen RA, Peet AC. In vitro metabonomic study detects increases in UDP-GlcNAc and UDP-GalNAc, as early phase markers of cisplatin treatment response in brain tumor cells. J Proteome Res. 2011 Aug 5;10(8):3493-500. doi: 10.1021/pr200114v. Epub 2011 Jun 27. PMID: 21644796.
| Cas No. | 91183-98-1 | SDF | |
| Canonical SMILES | O[C@H]1[C@H](N2C(NC(C=C2)=O)=O)O[C@H](COP(OP(O[C@@H]3[C@@H]([C@H]([C@H](O)[C@@H](CO)O3)O)NC(C)=O)([O-])=O)([O-])=O)[C@H]1O.[Na+].[Na+] | ||
| Formula | C17H25N3Na2O17P2 | M.Wt | 651.32 |
| 溶解度 | PBS (pH 7.2): 10 mg/ml | Storage | Store at -20°C,protect from light,unstable in solution, ready to use. |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 1.5353 mL | 7.6767 mL | 15.3534 mL |
| 5 mM | 0.3071 mL | 1.5353 mL | 3.0707 mL |
| 10 mM | 0.1535 mL | 0.7677 mL | 1.5353 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 31 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *